New combo therapy targets large tumors that returned after treatment
NCT ID NCT06936748
First seen May 11, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This study tests a new way to treat large solid tumors that have come back or not responded to standard treatments. It combines a special type of radiation therapy with two immunotherapy drugs to help the immune system fight the cancer. The goal is to see if this approach is safe and can shrink tumors. About 30 adults aged 18 to 75 with bulky tumors (over 6 cm) that cannot be removed by surgery are eligible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.